Parametric Portfolio Associates’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-95,296
| Closed | -$581K | – | 3749 |
|
2021
Q3 | $581K | Buy |
95,296
+59,522
| +166% | +$363K | ﹤0.01% | 3035 |
|
2021
Q2 | $294K | Buy |
35,774
+13,549
| +61% | +$111K | ﹤0.01% | 3276 |
|
2021
Q1 | $199K | Buy |
22,225
+8,668
| +64% | +$77.6K | ﹤0.01% | 3881 |
|
2020
Q4 | $156K | Buy |
13,557
+2,957
| +28% | +$34K | ﹤0.01% | 3831 |
|
2020
Q3 | $110K | Buy |
10,600
+149
| +1% | +$1.55K | ﹤0.01% | 3780 |
|
2020
Q2 | $137K | Sell |
10,451
-4,220
| -29% | -$55.3K | ﹤0.01% | 3720 |
|
2020
Q1 | $115K | Sell |
14,671
-2,880
| -16% | -$22.6K | ﹤0.01% | 3695 |
|
2019
Q4 | $363K | Sell |
17,551
-6,208
| -26% | -$128K | ﹤0.01% | 3496 |
|
2019
Q3 | $326K | Buy |
23,759
+3,878
| +20% | +$53.2K | ﹤0.01% | 3499 |
|
2019
Q2 | $245K | Buy |
19,881
+6,413
| +48% | +$79K | ﹤0.01% | 3660 |
|
2019
Q1 | $168K | Sell |
13,468
-5,150
| -28% | -$64.2K | ﹤0.01% | 3747 |
|
2018
Q4 | $211K | Buy |
18,618
+1,923
| +12% | +$21.8K | ﹤0.01% | 3645 |
|
2018
Q3 | $312K | Sell |
16,695
-1,755
| -10% | -$32.8K | ﹤0.01% | 3597 |
|
2018
Q2 | $477K | Sell |
18,450
-110
| -0.6% | -$2.84K | ﹤0.01% | 3366 |
|
2018
Q1 | $416K | Buy |
18,560
+384
| +2% | +$8.61K | ﹤0.01% | 3433 |
|
2017
Q4 | $455K | Buy |
18,176
+1,106
| +6% | +$27.7K | ﹤0.01% | 3375 |
|
2017
Q3 | $413K | Buy |
17,070
+873
| +5% | +$21.1K | ﹤0.01% | 3532 |
|
2017
Q2 | $328K | Sell |
16,197
-11,403
| -41% | -$231K | ﹤0.01% | 3590 |
|
2017
Q1 | $743K | Buy |
27,600
+12,181
| +79% | +$328K | ﹤0.01% | 3012 |
|
2016
Q4 | $293K | Sell |
15,419
-2,036
| -12% | -$38.7K | ﹤0.01% | 3436 |
|
2016
Q3 | $341K | Hold |
17,455
| – | – | ﹤0.01% | 3359 |
|
2016
Q2 | $261K | Buy |
+17,455
| New | +$261K | ﹤0.01% | 3503 |
|